Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06950372

Ropivacaine Concentration and Rebound Pain

Rebound Pain After Volar Plate Surgery in Infraclavicular Brachial Plexus Block With Ropivacaine 3.75 mg/ml Compared With 7.5 mg/ml. A Prospective, Parallelgroup, 2-arm, Triple Blinded Randomised Controlled Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to see if the concentration of a local anesthetic (ropivacaine) in peripheral nerve block is related to the severness of pain after surgery of distal radius fractures in adults. The main questions it aims to answer are: * Is concentration of ropivacaine related to severeness, duration and type of postoperative pain? * Is concentration of ropivacaine related to analgetic consumption after surgery? * Is concentration of ropivacaine related to block sucess rate during surgery and patient satisfaction after surgery? Researchers will compare ropivacaine 3.75 mg/ml and 7.5 mg/ml used in brachial plexus peripheral nerve block. Participipants are randomized to one of the two concentrations. The peripheral nerve block is standard anesthetic treatment for distal radius fractures scheduled for volar plate surgery at Oslo University Hospital. All other treatment for the condition will be the same as standard treatment. Participants will answer a questionnaire regarding pain, physical function, medication and life quality at different points of time after surgery, up to 6 weeks after surgery.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine concentration lowBrachial plexus nerve block with ropivacaine 3.75 mg/ml
DRUGRopivacaine concentration highBrachial plexus nerve block with ropivacaine 7.5 mg/ml

Timeline

Start date
2025-02-14
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-04-30
Last updated
2025-04-30

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT06950372. Inclusion in this directory is not an endorsement.